432 filings
Page 4 of 22
8-K
mboxznddmyr 6fn
26 Oct 21
Other Events
8:00am
8-K
0j19l7r 890u
16 Aug 21
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
4:01pm
EFFECT
nc3aon
7 Jun 21
Notice of effectiveness
12:15am
POS AM
b8ry1q6z53o0t t67p
18 May 21
Prospectus update (post-effective amendment)
12:00am
S-8
w674w
18 May 21
Registration of securities for employees
12:00am
8-K
5wt4 jt31h
17 May 21
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
5:27pm
8-K
bjwpvrevlep2
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
e85 6o5og
25 Mar 21
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
9:17am
425
nqk28cdrae
25 Mar 21
Business combination disclosure
9:15am
8-K
zopclh84m
16 Mar 21
Other Events
7:02am
425
uw46mo 8htyx
16 Mar 21
Business combination disclosure
7:00am
DEFR14A
63wx331lk
26 Feb 21
Revised proxy
4:46pm
8-K
xc1ng
26 Feb 21
Entry into a Material Definitive Agreement
4:42pm
425
0ur0r4azfm mind
26 Feb 21
Business combination disclosure
4:40pm
8-K
6qqvjlqstg8jn8xni3vu
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
424B5
flsngcnh qis
16 Feb 21
Prospectus supplement for primary offering
12:00am